Vivanta Care Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.4/10
Best for: budget-minded starters who want to see GLP-1 prices before any health questions
Price is where Vivanta Care scores best in our breakdown.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Vivanta Care is a telehealth platform that connects patients with MD Integrations clinicians for compounded semaglutide and tirzepatide, filled by DiRx pharmacy, alongside hormone and longevity programs. The price rises with your dose stage: semaglutide runs $79 to $299 a month and tirzepatide $99 to $329, billed monthly with the provider review and shipping included. Each stage's price is shown before the health intake.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Vivanta Care
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
Editorial score · methodology
Vivanta Care at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $79/mo (One 2.5 mg/mL, 0.5 mL vial per order; the lowest of four dose-stage prices)
- Pricing model
- Scales with dose — higher doses cost more
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Vivanta Care
Each dimension is scored algorithmically from Vivanta Care’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.8/10At $79/mo, Vivanta Care runs about 53% below the $169 median for GLP-1 providers. Note the price scales with dose, so budget for higher tiers as you titrate.
Effectiveness25%
7.8/10Vivanta Care offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.1/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
7.0/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
6.2/10Vivanta Care's exact state footprint isn't published — confirm coverage in your state before signing up. FSA/HSA cards are accepted.
Support10%
5.6/10Vivanta Care provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Vivanta Care review
Last checked October 2026- Confirmed current pricing across 8 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $79–$329/mo across 8 dose/plan tiers — checked October 2026
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Vivanta Care
We walked Vivanta Care’s public signup flow in October 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Pick semaglutide or tirzepatide from the programs page and choose "Start medical intake"
- 2Choose your dose stage (Starting, Building, Regular, Higher or restarting); each one shows its monthly price
- 3A match screen confirms the drug and the "from" price, then opens a separate intake site
- 4Answer 13 health questions: state, height and weight, goal, past bariatric surgery, conditions, GLP-1 safety screens, medications, allergies and pregnancy
- 5Review your answers and accept the telehealth consent
- 6Checkout asks for your name, date of birth, email, phone, shipping address and card, plus five consents (walk stopped here, nothing entered)
- Prices appear on the dose-stage screen before any health question, and the checkout total matched them: $79 for starting semaglutide, $99 for starting tirzepatide
- Checkout lists the provider review and treatment plan as included and shipping as free, with the whole amount due today
- You pay before a clinician reviews the intake; the checkout says payment for unshipped medication is refunded if you are not approved
- The FAQ promises one price at every dose, while the dose-stage screen charges $79 to $299 for semaglutide and $99 to $329 for tirzepatide
- The GLP-1 page mentions a $75 consultation fee at checkout; the checkout showed none, and the $75 applies to an optional live video visit
- The intake screens for pancreatitis, medullary thyroid cancer history, MEN-2, type 1 diabetes and pregnancy
- The plan renews monthly until you cancel from your account or by email
Vivanta Care customer support
- Phone
- +1 805-206-3730
- Hours
- Monday to Saturday
GLP-1 medications Vivanta Care offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
One 2.5 mg/mL, 0.5 mL vial per order; the lowest of four dose-stage prices
One 2.5 mg/mL, 4 mL vial per order; price rises with each dose stage
One 5 mg/mL, 5 mL vial per order; price rises with each dose stage
One 10 mg/mL, 5 mL vial per order; price rises with each dose stage
One 10 mg/mL, 1 mL vial per order; the lowest of four dose-stage prices
One 10 mg/mL, 3 mL vial per order; price rises with each dose stage
One 15 mg/mL, 4 mL vial per order; price rises with each dose stage
One 20 mg/mL, 5 mL vial per order; price rises with each dose stage
Ready to get started?
Plans and promotions change often — check Vivanta Care's current pricing and active discounts before you decide.
What we like
- Every dose-stage price is on screen before the health intake: semaglutide from $79 and tirzepatide from $99 a month
- Checkout lists the provider review and shipping as included, with no membership fee and no consultation charge for the online intake
- Names who does the work: clinicians through MD Integrations and DiRx, a Florida pharmacy listed with its address and hours
- Month-to-month billing that you can cancel any time from your account or by email
- If a clinician doesn't approve treatment, payment for medication that hasn't shipped is refunded
- Publishes a phone number and email, plus an optional $75 live video visit for people who want to talk to a clinician
- FSA and HSA cards are accepted for eligible expenses
Watch-outs
- The price rises with your dose: semaglutide climbs from $79 to $299 a month and tirzepatide from $99 to $329
- The FAQ says pricing stays the same at every dose, which the dose-stage price screen contradicts
- The GLP-1 page says a $75 consultation fee is charged at checkout, but checkout showed no such fee for the online intake
- The $79 semaglutide stage is one 0.5 mL vial (1.25 mg), which runs short of a month at the 0.5 mg weekly dose its label mentions
- Top-tier labels read "often 10 mg weekly" semaglutide and "often 20–25 mg weekly" tirzepatide, above the highest brand-name doses
- You pay at checkout before a clinician reviews your intake, and shipped medication is non-refundable
- The site's medical-group section leaves the group's name blank, and the company's home state of registration isn't given
- A young brand whose site went up in 2026; the homepage reviews are first-name-and-initial quotes with no outside rating to check
Is Vivanta Care worth it?
Vivanta Care's whole pitch comes down to this: budget-minded starters who want to see GLP-1 prices before any health questions. It runs $79/month — toward the affordable end of the category, so cost isn't the reason to look elsewhere. It's a fairly plain, no-frills entry in the glp-1 providers category, without a lot of extra add-ons layered on top of the medication itself.
Vivanta Care is LegitScript-certified. It also charges no membership fee and takes HSA/FSA payment.
How much Vivanta Care actually costs
Compounded semaglutide runs $79/month, compounded semaglutide runs $169/month, compounded semaglutide runs $229/month, compounded semaglutide runs $299/month, compounded tirzepatide runs $99/month, compounded tirzepatide runs $139/month, compounded tirzepatide runs $249/month, and compounded tirzepatide runs $329/month.
That puts Vivanta Care below the roughly $169 median ongoing price across the GLP-1 providers we track — a real cost advantage.
Embody (about $79/month) is one of the closest alternatives to weigh Vivanta Care against.
Medications: what Vivanta Care prescribes
Vivanta Care prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two most-studied weight-loss molecules on the market today. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Who Vivanta Care is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost — $79/month is below the roughly $169 median we track across the category.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation — that's not what this provider fills.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement — read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Vivanta Care earns its place on the shortlist mainly on price: at $79/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
The Bottom Line
Price is where Vivanta Care scores best in our breakdown.
Ready to start with Vivanta Care?
Starting at $79/month. See current pricing and start your free consultation.
Vivanta Care might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Found.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Vivanta Care review:
Sources & methodology — as of October 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Vivanta Care's current pricing
Plans start at $79/month. Start your free consultation to check eligibility and today's price.